Fu_2022_Biotechnol.Appl.Biochem__

Ovarian cancer ranks seventh in the most common malignant tumors in females and seriously threatens women's reproductive health. Natural sources may lead to basic research on potential bioactive components as lead compounds in drug discovery and ultimately therapeutic treatments for ovarian cancer and other diseases. sAlzheimer's disease and ovarian cancer are complex diseases of aging that impose an enormous public health burden worldwide.s Additionally, People with Alzheimer's disease have low levels of acetylcholine in their brain. Enzymes called cholinesterases break down acetylcholine in the brain. If their action is inhibited, more acetylcholine is available for communication between brain cells. In this study, pregnanolone, diethylstilbestrol, flavokawain C, methyl 3,4,5-trihydroxybenzoate molecules obtained excellent to good inhibitory against acetylcholinesterase and butyrylcholinesterase enzymes with IC(50) values ranging between 77.18+/-8.62 to 461.35+/-28.54 microM for acetylcholinesterase and 23.86+/-4.07 to 306.62+/-32.46 microM for butyrylcholinesterase. The calculations revealed the probable interactions and their characteristics at an atomic level. Indeed, the docking scores of diethylstilbestrol, flavokawain C, pregnanolone, and methyl 3,4,5-trihydroxybenzoate for AChE are -6.685, -6.247, -6.672, and -5.183 (kcal/mol), respectively. This value for the compounds against BuChE is -6.042, -8.851, -5.655, and -5.898 (kcal/mol), respectively. Additionally, these compounds significantly decreased ovarian cancer cell viability. Additionally, 100 microM dose of all molecules caused good reductions in ovarian cancer cell viability. This article is protected by copyright. All rights reserved.